AGÕæÈ˹ٷ½

STOCK TITAN
  1. Home
  2. Sec-filings
  3. ZURA
  4. [SCHEDULE 13G] Zura Bio Limited SEC Filing

[SCHEDULE 13G] Zura Bio Limited SEC Filing

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
SCHEDULE 13G

Filing content is currently unavailable.

Source:

Stock ZURA logo
Zura Bio Limited

NASDAQ:ZURA

ZURA Rankings

#4802 Ranked by Market Cap
N/A Ranked by Dividends
#160 Top Gainer

ZURA Latest News

Aug 14, 2025
Zura Bio Reports Second Quarter 2025 Financial Results and Recent Corporate Updates
Jul 17, 2025
Zura Bio Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Jul 1, 2025
Zura Bio Announces Chief Financial Officer Transition
May 27, 2025
Zura Bio to Present at the Jefferies Global Healthcare Conference
May 20, 2025
Zura Bio Launches Global Phase 2 TibuSHIELD Study to Evaluate Tibulizumab in Adults with Hidradenitis Suppurativa

ZURA Latest SEC Filings

Aug 14, 2025
[SCHEDULE 13G/A] Zura Bio Limited SEC Filing
Aug 14, 2025
[10-Q] Zura Bio Limited Quarterly Earnings Report
Aug 14, 2025
[8-K] Zura Bio Limited Reports Material Event
Jul 17, 2025
[Form 4] Zura Bio Limited Insider Trading Activity
Jul 17, 2025
[Form 3] Zura Bio Limited Initial Statement of Beneficial Ownership

ZURA Stock Data

87.24M
43.83M
29.16%
70.82%
0.95%
Biotechnology
Biological Products, (no Disgnostic Substances)
United States
LA JOLLA